Comparison of tissue and plasma levels of ibuprofen after oral and topical administration

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 12, 1996, Pages 1138-1143

  Dominkus, Martin ^a   Nicolakis, Michael ^a   Kotz, Rainer ^a   Wilkinson, Fay E ^c   Kaiser, R Renato ^c   Chlud, Karl ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c Medinova Ltd   (Switzerland)

Author keywords

anti inflammatories, non steroidal; CAS 15687 27 1; ibugel ; ibuprofen, absorption, oral, penetration, percutaneous

Indexed keywords

IBUPROFEN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KNEE; KNEE DISEASE; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GELS; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; SPECTROPHOTOMETRY, ULTRAVIOLET; SYNOVIAL FLUID; TISSUE DISTRIBUTION;

EID: 0030475682     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Busson, M., J. Int. Med. Res. 14, 53 (1986)
2. Chlud, K., Wagener, H. H., EULAR Bull. 2, 40 (1987)
3. Monography, Brufen: Experimental, Technical and Clinical Aspects of Brufen, The Boots Company PLC, Nottingham, England (1985)
4. Wallis, W. J., Simkin, P. A., Clin. Pharmacokinet. 8, 496 (1983)
5. Whitlam, J. B., Brown, K. F., Crooks, M. J. et al., Clin. Pharmacol. Ther. 29, 487 (1981)
6. Brune, K., Fortschr. Med. 104, 483 (1986)
7. Mondino, A., Zanolo, G., Giachetti, C. et al., Med. Welt 34, 1052 (1983)
8. Lockwood, G. F., Albert, K. S., Gillespie, W. R. et al., Clin. Pharmacol. Ther. 34, 97 (1983)
9. Kleinbloesem, C., Ouwerkerk, M., Spitznagel, W. et al., Arzneim.-Forsch./Drug Res. 45 (II), 1117 (1995)
10. Berner, G., Engels, B., Vögtle-Junkert, U., Med. Welt 40, 1024 (1989)
11. Berner, G., Engels, B., Vögtle-Junkert, U., Drugs Exp. Clin. Res. XV, 559 (1989)
12. Seth, P. L., Arzneim.-Forsch./Drug Res. 43, 919 (1993)
13. Bertsch, K., Abberger, H., 2nd European Federation for Pharmaceutical Sciences (EUFEPS) Nuremberg Conference: Symposium on Quality and Interchangeability of Topical Products for Local Action, Nuremberg, Germany, Dec. 8-9, 1995
14. Meier, G., Vögtle-Junkert, U., Berner, G. et al., EULAR Bull. 3, 90 (1990)
15. Cushman, D. W., Cheung, H. S., Biochim. Biophys. Acta 424, 449 (1976)
16. Final study report. Protocol No. CPR 93-510 (1993)
17. Chlud, K., Berner, G., Wagener, H. H., Therapiewoche 35, 2872 (1985)
18. Peters, H., Chlud, K., Berner, G. et al., Akt. Rheumatol. 12, 208 (1987)
19. Vögtle-Junkert, U., Peters, H., Berner, G. et al., Akt. Rheumatol. 15, 56 (1990)